DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 802 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,479,000 | +4.6% | 42,237 | +1.2% | 0.44% | +10.0% |
| Q2 2023 | $10,016,880 | -4.6% | 41,737 | +0.2% | 0.40% | -8.7% |
| Q1 2023 | $10,502,003 | -6.2% | 41,668 | -1.3% | 0.44% | -6.0% |
| Q4 2022 | $11,201,520 | -5.4% | 42,203 | -8.0% | 0.46% | -9.5% |
| Q3 2022 | $11,843,000 | -14.5% | 45,853 | -16.1% | 0.51% | -10.9% |
| Q2 2022 | $13,859,000 | -13.0% | 54,668 | +0.7% | 0.58% | +6.9% |
| Q1 2022 | $15,921,000 | -12.0% | 54,276 | -1.3% | 0.54% | +2.3% |
| Q4 2021 | $18,089,000 | +5.4% | 54,980 | -2.5% | 0.53% | -1.1% |
| Q3 2021 | $17,165,000 | +14.4% | 56,381 | +0.8% | 0.53% | +15.6% |
| Q2 2021 | $15,005,000 | +6.7% | 55,914 | -10.5% | 0.46% | -1.3% |
| Q1 2021 | $14,061,000 | -1.5% | 62,471 | -2.8% | 0.47% | -6.4% |
| Q4 2020 | $14,281,000 | +3.0% | 64,288 | -0.2% | 0.50% | -18.6% |
| Q3 2020 | $13,864,000 | +21.7% | 64,387 | -0.1% | 0.61% | +12.0% |
| Q2 2020 | $11,393,000 | +64.8% | 64,427 | +29.0% | 0.55% | +22.3% |
| Q1 2020 | $6,912,000 | -11.7% | 49,936 | -2.1% | 0.45% | +21.7% |
| Q4 2019 | $7,828,000 | +6.3% | 51,006 | +0.0% | 0.37% | -3.4% |
| Q3 2019 | $7,367,000 | +0.4% | 51,005 | -0.6% | 0.38% | -3.1% |
| Q2 2019 | $7,335,000 | +8.3% | 51,324 | +0.1% | 0.39% | +2.3% |
| Q1 2019 | $6,772,000 | +30.2% | 51,295 | +1.7% | 0.38% | +1.1% |
| Q4 2018 | $5,201,000 | -6.6% | 50,441 | -1.6% | 0.38% | +18.8% |
| Q3 2018 | $5,568,000 | +9.9% | 51,240 | -0.2% | 0.32% | -0.3% |
| Q2 2018 | $5,066,000 | -0.1% | 51,340 | -0.9% | 0.32% | -5.3% |
| Q1 2018 | $5,073,000 | +5.5% | 51,815 | 0.0% | 0.34% | +11.9% |
| Q4 2017 | $4,809,000 | +4.7% | 51,815 | -3.3% | 0.30% | +5.9% |
| Q3 2017 | $4,595,000 | +1.7% | 53,565 | 0.0% | 0.29% | -6.2% |
| Q2 2017 | $4,520,000 | -1.3% | 53,565 | 0.0% | 0.30% | -2.9% |
| Q1 2017 | $4,581,000 | +9.9% | 53,565 | 0.0% | 0.31% | +2.3% |
| Q4 2016 | $4,170,000 | -21.5% | 53,565 | -21.0% | 0.31% | -22.5% |
| Q3 2016 | $5,312,000 | -22.4% | 67,765 | 0.0% | 0.40% | -26.5% |
| Q2 2016 | $6,844,000 | +6.5% | 67,765 | 0.0% | 0.54% | -7.4% |
| Q1 2016 | $6,428,000 | -1.9% | 67,765 | -4.0% | 0.58% | -1.7% |
| Q4 2015 | $6,554,000 | +14.5% | 70,565 | +5.1% | 0.59% | +7.6% |
| Q3 2015 | $5,723,000 | -0.5% | 67,165 | 0.0% | 0.55% | +3.6% |
| Q2 2015 | $5,749,000 | -2.9% | 67,165 | -3.7% | 0.53% | +4.1% |
| Q1 2015 | $5,923,000 | -1.0% | 69,765 | 0.0% | 0.51% | -24.1% |
| Q4 2014 | $5,980,000 | +20.5% | 69,765 | +6.8% | 0.67% | -1.0% |
| Q3 2014 | $4,963,000 | -10.5% | 65,315 | -7.2% | 0.68% | -13.7% |
| Q2 2014 | $5,544,000 | -2.0% | 70,415 | -6.7% | 0.79% | -10.7% |
| Q1 2014 | $5,660,000 | -2.8% | 75,465 | 0.0% | 0.88% | -1.7% |
| Q4 2013 | $5,826,000 | +11.4% | 75,465 | 0.0% | 0.90% | +5.7% |
| Q3 2013 | $5,231,000 | +9.5% | 75,465 | 0.0% | 0.85% | +0.5% |
| Q2 2013 | $4,777,000 | – | 75,465 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |